We are live on
!
Find out more
MVP
Miller Value Partners Portfolio holdings
AUM
$423M
1-Year Est. Return
49.14%
This Fund
S&P 500
This Quarter
Est. Return
-0.05%
1 Year Est. Return
+49.14%
3 Year Est. Return
+132.73%
5 Year Est. Return
+100.12%
10 Year Est. Return
+859.21%
AUM
$2.4B
AUM Growth
+$48.9M
(+2.1%)
Cap. Flow
+$71.5M
Cap. Flow
% of AUM
2.98%
Top 10 Holdings %
Top 10 Hldgs %
40%
Holding
119
New
7
Increased
33
Reduced
36
Closed
9
Avg Time Held Equity + Options
7.1
quarters
Top 10 Avg Time Held Equity + Options
4.7
quarters
Top 20 Avg Time Held Equity + Options
8.3
quarters
Avg Time Held Equity only
7.1
quarters
Top 10 Avg Time Held Equity only
6
quarters
Top 20 Avg Time Held Equity only
9.2
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$39.5M |
| 2 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$32.8M |
| 3 |
AGN
Allergan plc
AGN
|
+$18.9M |
| 4 |
Lumen Technologies, Inc. Common Stock
LUMN
|
+$13.5M |
| 5 |
ENDP
Endo International plc
ENDP
|
+$12.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$24.8M |
| 2 |
GameStop
GME
|
+$17.4M |
| 3 |
MGIC Investment
MTG
|
+$16.2M |
| 4 |
Wayfair
W
|
+$11.6M |
| 5 |
Amazon
AMZN
|
+$6.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 24.56% |
| 2 | Healthcare | 20.81% |
| 3 | Financials | 15.68% |
| 4 | Industrials | 11.05% |
| 5 | Communication Services | 10.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Amazon
AMZN
$2.8T
| $164M | 6.85% |
2,270,560
-92,240
| -4% | -$6.6M |
2013 Q2
19 quarters
|
|
2
RH
RH
$2.21B
| $125M | 5.21% |
1,313,180
-29,030
| -2% | -$2.57M |
2016 Q4
5 quarters
|
|
3
OneMain Financial
OMF
$6.44B
| $108M | 4.51% |
3,611,660
-77,875
| -2% | -$2.47M |
2013 Q4
17 quarters
|
|
|
4
Bausch Health
BHC
$2.22B
| $86.2M | 3.59% |
5,414,064
-1,334,095
| -20% | -$24.8M |
2016 Q1
8 quarters
|
|
5
Delta Air Lines
DAL
$52.7B
| $85.6M | 3.57% |
1,561,700
-96,835
| -6% | -$5.34M |
2013 Q2
19 quarters
|
|
6
DELISTED
JPMorgan Chase
JPM.WS
| $84.9M | 3.54% |
1,221,100
-23,125
| -2% | -$1.69M |
2013 Q2
19 quarters
|
|
7
Lennar Class A
LEN
$17.8B
| $81.7M | 3.41% |
1,431,970
-24,508
| -2% | -$1.48M |
2013 Q2
19 quarters
|
|
8
American Airlines Group
AAL
$8.35B
| $79.9M | 3.33% |
1,537,750
-96,450
| -6% | -$5.17M |
2013 Q4
17 quarters
|
|
9
Precigen
PGEN
$2.74B
| $73.7M | 3.07% |
4,810,000
+225,825
| +5% | +$3.23M |
2013 Q4
17 quarters
|
|
10
United Airlines
UAL
$33.9B
| $70.2M | 2.93% |
1,010,825
-32,680
| -3% | -$2.26M |
2013 Q2
19 quarters
|
|
|
QUOT
11
DELISTED
Quotient Technology Inc
QUOT
| $69.1M | 2.88% |
5,275,825
-245,191
| -4% | -$3.1M |
2014 Q1
16 quarters
|
|
12
Bank of America
BAC
$382B
| $66.6M | 2.78% |
2,221,264
-131,100
| -6% | -$4.12M |
2013 Q2
19 quarters
|
|
13
Pultegroup
PHM
$21.2B
| $63.1M | 2.63% |
2,139,975
-67,900
| -3% | -$2.11M |
2013 Q2
19 quarters
|
|
14
DELISTED
Foot Locker
FL
| $62.9M | 2.62% |
1,380,400
-33,275
| -2% | -$1.55M |
2017 Q2
3 quarters
|
|
15
Element Solutions
ESI
$8.88B
| $62M | 2.58% |
6,434,325
-556,975
| -8% | -$5.95M |
2014 Q4
13 quarters
|
|
16
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $59.8M | 2.49% |
2,669,900
-14,600
| -0.5% | -$356K |
2017 Q2
3 quarters
|
|
|
17
Lumen Technologies, Inc. Common Stock
LUMN
$5.21B
| $58.6M | 2.44% |
3,567,435
+780,985
| +28% | +$13.5M |
2017 Q4
1 quarter
|
|
|
ENDP
18
DELISTED
Endo International plc
ENDP
| $57.9M | 2.41% |
9,746,330
+1,830,305
| +23% | +$12.8M |
2016 Q2
7 quarters
|
|
19
Genworth Financial
GNW
$3.42B
| $55M | 2.29% |
19,423,255
+586,750
| +3% | +$1.76M |
2013 Q2
19 quarters
|
|
20
CALL
Apple
AAPL
$4.98T
| $47.8M | 1.99% |
1,138,400
-910,800
| -44% | -$39.2M |
2014 Q2
15 quarters
|
|
|
EIGI
21
DELISTED
Endurance International Group Holdings, Inc.
EIGI
| $47.1M | 1.96% |
6,364,775
-154,503
| -2% | -$1.23M |
2014 Q4
13 quarters
|
|
|
ALXN
22
DELISTED
Alexion Pharmaceuticals
ALXN
| $46.9M | 1.96% |
421,065
-15,800
| -4% | -$1.89M |
2016 Q4
5 quarters
|
|
|
AGN
23
DELISTED
Allergan plc
AGN
| $45.7M | 1.91% |
271,810
+112,685
| +71% | +$18.9M |
2016 Q4
5 quarters
|
|
24
DELISTED
Warner Bros
WBD
| $44.6M | 1.86% |
2,079,225
+376,425
| +22% | +$8.95M |
2017 Q4
1 quarter
|
|
25
Meta Platforms (Facebook)
META
$1.89T
| $44.3M | 1.85% |
277,270
+54,205
| +24% | +$9.73M |
2017 Q2
3 quarters
|
|
Similar funds
WPC
ACM
BA
WTFG
MWP
MAMA
MI
AFWM
Miller Value Partners's Q1 2018 Portfolio in Review
As of Q1 2018, Miller Value Partners held 119 positions worth $2.4B, up 2.1% from $2.35B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Miller Value Partners's Q1 2018 filing shows 7 new, 33 increased, 36 reduced and 9 closed positions. Its largest new stake was Micron Technology: 200,000 shares worth $10.4M. The largest sale was Bausch Health, an estimated $24.8M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.
- Miller Value Partners's largest Q1 2018 buy was Micron Technology: 200,000 shares worth $10.4M.
- Miller Value Partners added most to Celgene Corp in Q1 2018, an estimated $39.5M increase.
- Miller Value Partners's biggest Q1 2018 reduction was Bausch Health, cutting an estimated $24.8M.
- Miller Value Partners fully exited CalAtlantic Group, Inc. in Q1 2018, selling an estimated $5.64M.
- Miller Value Partners's ten largest holdings make up 40% of its $2.4B portfolio in Q1 2018.
- Miller Value Partners opened 7 new positions and closed 9 in Q1 2018.
- Miller Value Partners's portfolio value rose 2.1% quarter-over-quarter to $2.4B.
Based on Miller Value Partners's 13F filing for Q1 2018, filed 15 May 2018.